Overview
Cbd, or cannabidiol, is a non-psychoactive compound found in the cannabis plant, with a growing body of research on its potential health benefits, including reducing inflammation and anxiety. Meanwhile, a central business district (CBD) is the commercial and financial hub of a city, often featuring iconic skyscrapers and bustling streets. With a vibe rating of 72, the topic of cbd is surrounded by controversy and debate, particularly regarding its legality and efficacy. As of 2024, the global cannabidiol market is projected to reach $13.4 billion by 2028, with major players like [[charlotte-s-web|Charlotte's Web]] and [[cv-sciences|CV Sciences]] leading the charge. The World Health Organization (WHO) has recognized the potential therapeutic benefits of cannabidiol, and the National Institutes of Health (NIH) has funded numerous studies on its effects. However, the US Food and Drug Administration (FDA) has only approved one cannabidiol-based medication, [[epidiolex|Epidiolex]], for the treatment of certain seizure disorders.